Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹863.75
Market cap: ₹16,978 Cr
Revenue (annual): ₹7,345 Cr
Net profit (annual): ₹674.8 Cr
P/E (TTM): 24.5×Sector 50.4×
Promoter holding: 69.87%+0.13% QoQ
FII holding: 4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 3 Debt & Borrowing 3 Merger & Restructuring 2 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

4 Aug 2026 14:06 IST NSE

Financial Results

Alembic Pharmaceuticals Q1 FY27 Results: Net Profit ₹173.1 Cr, Up 12.1% YoY

Alembic Pharmaceuticals Ltd reported revenue from operations of ₹2,150 Cr (+25.7% YoY) and net profit of ₹173.1 Cr (+12.1% YoY) for Q1 FY27.

Key figure: Net profit ₹173.1 Cr · +12.1% YoY

Open full results → Read the filing ↗

15 May 2026 14:50 IST NSE

Financial ResultsAlfa Alert

Alembic Pharmaceuticals Q4 FY26 Results: Net Profit ₹202.7 Cr, Up 29.2% YoY

Alembic Pharmaceuticals Ltd reported revenue from operations of ₹1,848 Cr (+4.4% YoY) and net profit of ₹202.7 Cr (+29.2% YoY) for Q4 FY26.

Key figure: Net profit ₹202.7 Cr · +29.2% YoY

Open full results → Read the filing ↗

15 May 2026 14:46 IST BSE

Financial ResultsAlfa Alert

Alembic Pharmaceuticals Q4 FY26 Results: Net Profit ₹201.5 Cr, Up 28.7% YoY

Alembic Pharmaceuticals Ltd reported revenue from operations of ₹1,848 Cr (+4.4% YoY) and net profit of ₹201.5 Cr (+28.7% YoY) for Q4 FY26.

Key figure: Net profit ₹201.5 Cr · +28.7% YoY

Open full results → Read the filing ↗